Broadening the Net: Overcoming Challenges and Embracing Novel Technologies in Lung Cancer Screening

Area of Science:

• Oncology
• Radiology
• Public Health

Background:

• Lung cancer is a leading cause of cancer mortality, often diagnosed at late stages.
• Low-dose computed tomography (LDCT) for lung cancer screening (LCS) reduces mortality but faces low uptake.
• Current eligibility criteria for LCS are imperfect and exclude at-risk individuals.

Purpose of the Study:

• To review global obstacles in implementing LCS programs.
• To discuss strategies for overcoming barriers in resource-limited settings.
• To explore opportunities for enhancing LCS in underserved populations and through novel technologies.

Main Methods:

• Review of existing literature on LCS implementation and effectiveness.
• Analysis of successful community engagement strategies for LCS promotion.
• Examination of emerging technologies, including artificial intelligence, for early detection.

Main Results:

• LCS with LDCT demonstrates a significant reduction in lung cancer-specific mortality.
• Barriers to LCS uptake include imperfect eligibility criteria and recruitment challenges.
• Community partnerships and novel technologies offer opportunities to improve LCS reach and effectiveness.

Conclusions:

• LCS is effective in reducing lung cancer mortality, but uptake remains a challenge.
• Addressing implementation barriers and expanding screening criteria are essential.
• Future efforts should focus on inclusive screening strategies and leveraging AI for early detection in at-risk populations.